Opaleye Management reported a 9.48% stake in Karyopharm Therapeutics KPTI · 1,569,002 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9.48%
Last report: First report
Shares held: 1,569,002 sh
Class: Common Stock, no par value
Stock: Karyopharm Therapeutics KPTI
Holder: Opaleye Management
Event date: 25/10/10
Filed: 25/10/17

First 5%+ report · 9.48% stake

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/10~25/11/09

Opaleye Management's other 5% stake reports

Opaleye Management
5% stakeGrace Therapeutics
5% stake
Grace Therapeutics
GRCE
13.07% stake
2,748,392 sh
13.07% stake
Filed 08/07
Opaleye Management
5% stakeQ32 Bio
5% stake
Q32 Bio
QTTB
5.49% stake
931,000 sh
5.49% stake
Filed 07/31
Opaleye Management
5% stakeSanuwave Health
5% stake
Sanuwave Health
SNWV
3.6% stake
309,948 sh
3.6% stake
Filed 07/31
Opaleye Management
5% stakePasithea Therapeutics
5% stake
Pasithea Therapeutics
KTTA
6.14% stake
2,050,000 sh
6.14% stake
Filed 07/31
Opaleye Management
5% stakeHarrow
5% stake
Harrow
HROW
6.44% stake
2,400,000 sh
6.44% stake
Filed 07/31